BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23569343)

  • 1. Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.
    Zhang ZZ; Liu YJ; Yin XL; Zhan P; Gu Y; Ni XZ
    World J Gastroenterol; 2013 Mar; 19(12):1968-74. PubMed ID: 23569343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of serous ovarian cancer is associated with the expression of homologous recombination pathway proteins.
    Ye Q; Chen L; Yin X; Liu YJ; Ji Q; Zhao E
    Pathol Oncol Res; 2014 Oct; 20(4):931-8. PubMed ID: 24752797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer.
    Wei J; Costa C; Shen J; Yu L; Sanchez JJ; Qian X; Sun X; Zou Z; Gimenez-Capitan A; Yue G; Guan W; Rosell R; Liu B
    Br J Cancer; 2014 May; 110(11):2662-8. PubMed ID: 24809779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies.
    Gatei M; Zhou BB; Hobson K; Scott S; Young D; Khanna KK
    J Biol Chem; 2001 May; 276(20):17276-80. PubMed ID: 11278964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control.
    Lou Z; Chini CC; Minter-Dykhouse K; Chen J
    J Biol Chem; 2003 Apr; 278(16):13599-602. PubMed ID: 12611903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer.
    Ebi H; Matsuo K; Sugito N; Suzuki M; Osada H; Tajima K; Ueda R; Takahashi T
    Cancer Res; 2007 Dec; 67(23):11158-65. PubMed ID: 18056440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer.
    Grabsch H; Dattani M; Barker L; Maughan N; Maude K; Hansen O; Gabbert HE; Quirke P; Mueller W
    Clin Cancer Res; 2006 Mar; 12(5):1494-500. PubMed ID: 16533773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker.
    Kim JW; Im SA; Kim MA; Cho HJ; Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Lee HJ; Kim TY; Yang HK; Kim WH; Bang YJ
    Int J Cancer; 2014 Jan; 134(1):72-80. PubMed ID: 23649938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
    Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
    J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation at intronic repeats of the ataxia-telangiectasia mutated (ATM) gene and ATM protein loss in primary gastric cancer with microsatellite instability.
    Kim HS; Choi SI; Min HL; Kim MA; Kim WH
    PLoS One; 2013; 8(12):e82769. PubMed ID: 24324828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human syndromes with genomic instability and multiprotein machines that repair DNA double-strand breaks.
    De la Torre C; Pincheira J; López-Sáez JF
    Histol Histopathol; 2003 Jan; 18(1):225-43. PubMed ID: 12507302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.
    Lee B; Lee HJ; Cho HY; Suh DH; Kim K; No JH; Kim H; Kim YB
    Anticancer Res; 2015 Jul; 35(7):3909-16. PubMed ID: 26124337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair.
    Zhang J; Willers H; Feng Z; Ghosh JC; Kim S; Weaver DT; Chung JH; Powell SN; Xia F
    Mol Cell Biol; 2004 Jan; 24(2):708-18. PubMed ID: 14701743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1.
    Sivasubramaniam S; Sun X; Pan YR; Wang S; Lee EY
    Genes Dev; 2008 Mar; 22(5):587-600. PubMed ID: 18283122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.
    Zhang F; Bick G; Park JY; Andreassen PR
    J Cell Sci; 2012 Dec; 125(Pt 24):6049-57. PubMed ID: 23038782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase.
    Kolas NK; Chapman JR; Nakada S; Ylanko J; Chahwan R; Sweeney FD; Panier S; Mendez M; Wildenhain J; Thomson TM; Pelletier L; Jackson SP; Durocher D
    Science; 2007 Dec; 318(5856):1637-40. PubMed ID: 18006705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of MDC1 in Endometrial Carcinoma Is Associated With Loss of MRN Complex and MMR Deficiency.
    Merentitis D; Nguyen BD; Samartzis EP; Noske A; Brandt S; Dedes KJ
    Anticancer Res; 2019 Dec; 39(12):6547-6553. PubMed ID: 31810920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an Immunohistochemical Assay to Detect the Ataxia-Telangiectasia Mutated (ATM) Protein in Gastric Carcinoma.
    Miller RM; Nworu C; McKee L; Balcerzak D; Pham L; Pugh J; Liu YZ; Gustafson H; Marwah E; Lamb T; Clements J
    Appl Immunohistochem Mol Morphol; 2020 Apr; 28(4):303-310. PubMed ID: 31206368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-homologous end joining in class switch recombination: the beginning of the end.
    Kotnis A; Du L; Liu C; Popov SW; Pan-Hammarström Q
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):653-65. PubMed ID: 19008195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.